124 related articles for article (PubMed ID: 34097882)
1. The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
Garrido MM; Ribeiro RM; Pinheiro LC; Holdenrieder S; Guimarães JT
Clin Chim Acta; 2021 Sep; 520():133-138. PubMed ID: 34097882
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.
Boo Y; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Song W
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509551
[TBL] [Abstract][Full Text] [Related]
3. Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection.
Chiu ST; Cheng YT; Pu YS; Lu YC; Hong JH; Chung SD; Chiang CH; Huang CY
Front Oncol; 2021; 11():772182. PubMed ID: 34869007
[TBL] [Abstract][Full Text] [Related]
4. Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection.
Chen H; Qian Y; Wu Y; Shi B; Zhou J; Qu F; Gu Z; Ding J; Yu Y
Front Oncol; 2022; 12():864111. PubMed ID: 35463344
[TBL] [Abstract][Full Text] [Related]
5. The Value of the Prostate Health Index and Derived Indexes in the Diagnosis of Prostate Cancer with PI-RADS-3 Lesions.
Cui Y; Zhao J; Sun Y
Urol Int; 2023; 107(10-12):959-964. PubMed ID: 38011845
[TBL] [Abstract][Full Text] [Related]
6. Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies.
Schulze A; Christoph F; Sachs M; Schroeder J; Stephan C; Schostak M; Koenig F
Urol Int; 2020; 104(3-4):181-186. PubMed ID: 32224611
[TBL] [Abstract][Full Text] [Related]
7. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP
BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prostate-specific antigen isoform p2PSA and its derivates, %p2PSA, prostate health index and prostate dimension-adjusted related index in the detection of prostate cancer at first biopsy: an exploratory, prospective study.
Mearini L; Ferri C; Lazzeri M; Bini V; Nunzi E; Fiorini D; Costantini E; Manasse GC; Porena M
Urol Int; 2014; 93(2):135-45. PubMed ID: 24732975
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer.
Chen Y; Xu D; Ruan M; Li H; Lin G; Song G
Investig Clin Urol; 2023 Jul; 64(4):363-372. PubMed ID: 37417561
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study.
Wu B; Shao Y; Lin X; Hasi C; Jia W; Wang D; Cao X
Transl Androl Urol; 2023 Mar; 12(3):425-432. PubMed ID: 37032752
[TBL] [Abstract][Full Text] [Related]
11. Value of PHI and PHID in the detection of intermediate- and high-risk prostate cancer.
Filella X; Foj L; Wijngaard R; Luque P
Clin Chim Acta; 2022 Jun; 531():277-282. PubMed ID: 35483440
[TBL] [Abstract][Full Text] [Related]
12. Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.
Ferro M; Crocetto F; La Civita E; Fiorenza M; Jannuzzi G; Carbone G; Sirica R; Sicignano E; Pagano G; Imbimbo C; Terracciano D
Prostate; 2024 May; ():. PubMed ID: 38798011
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction With the In-bore 3-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy After Negative 12-Core Biopsy.
Friedl A; Stangl K; Bauer W; Kivaranovic D; Schneeweiss J; Susani M; Hruby S; Lusuardi L; Lomoschitz F; Eisenhuber-Stadler E; Schima W; Brössner C
Urology; 2017 Dec; 110():148-153. PubMed ID: 28844600
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.
Peters R; Stephan C; Jung K; Lein M; Friedersdorff F; Maxeiner A
Urol Int; 2022; 106(9):878-883. PubMed ID: 34433176
[TBL] [Abstract][Full Text] [Related]
15. Utility of Prostate Health Index Density for Biopsy Strategy in Biopsy-Naïve Patients With PI-RADS v2.1 Category 3 Lesions.
Kim MJ; Park JJ; Kang KA; Park SY; Kim CK
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38299766
[TBL] [Abstract][Full Text] [Related]
16. The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions.
Jagarlamudi KK; Zupan M; Kumer K; Fabjan T; Hlebič G; Eriksson S; Osredkar J; Smrkolj T
Prostate; 2019 Jun; 79(8):856-863. PubMed ID: 30889628
[TBL] [Abstract][Full Text] [Related]
17. PHI density prospectively improves prostate cancer detection.
Stephan C; Jung K; Lein M; Rochow H; Friedersdorff F; Maxeiner A
World J Urol; 2021 Sep; 39(9):3273-3279. PubMed ID: 33471165
[TBL] [Abstract][Full Text] [Related]
18. Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection.
Barisiene M; Bakavicius A; Stanciute D; Jurkeviciene J; Zelvys A; Ulys A; Vitkus D; Jankevicius F
Biomed Res Int; 2020; 2020():9872146. PubMed ID: 32775459
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of prostate health index to identify aggressive prostate cancer. An Institutional validation study.
Morote J; Celma A; Planas J; Placer J; Ferrer R; de Torres I; Pacciuci R; Olivan M
Actas Urol Esp; 2016; 40(6):378-85. PubMed ID: 26923032
[TBL] [Abstract][Full Text] [Related]
20. Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance.
Schwen ZR; Mamawala M; Tosoian JJ; Druskin SC; Ross AE; Sokoll LJ; Epstein JI; Carter HB; Gorin MA; Pavlovich CP
BJU Int; 2020 Sep; 126(3):373-378. PubMed ID: 32367635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]